Skip to main content
logo
Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
6.32
+0.76 (13.67%)
At close: Jul 2, 2026, 4:00 PM EDT
6.08
-0.24 (-3.80%)
After-hours: Jul 2, 2026, 7:59 PM EDT

UPC Revenue

In the fiscal year ending September 30, 2025, Universe Pharmaceuticals INC had annual revenue of $17.86B, down -22.44%. Universe Pharmaceuticals INC had revenue of $8.71M in the half year ending September 30, 2025, a decrease of -37.10%.

Revenue (ttm)
$17.86B
Revenue Growth
-22.44%
P/S Ratio
0.23
Revenue / Employee
$82,679
Employees
216
Market Cap
4.12M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202517.86B-5.17B-22.44%
Sep 30, 202423.02B-9.28B-28.74%
Sep 30, 202332.31B32.27B80,383.62%
Sep 30, 202240.14M-7.84M-16.34%
Sep 30, 202147.98M17.28M56.27%
Sep 30, 202030.70M-2.53M-7.60%
Sep 30, 201933.23M4.72M16.54%
Sep 30, 201828.51M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Biofrontera43.20M
Sunshine Biopharma35.49M
cbdMD19.98M
Sonoma Pharmaceuticals19.53M
InMed Pharmaceuticals4.94M
RedHill Biopharma286.00K
Gelteq270.85K
Akanda258.08K
Revenue Rankings

UPC News

More News